IPQ Inside the global regulatory dialogue

Existing Accelerated CMC, Advanced Manufacturing, and Inspection Initiatives are Supporting Regulators in Pandemic Response, FDA’s Cruse Explains in Recent Field Office Updates

Apr 7th, 2020

Please Log in to print the full article

FDA’s Multipronged COVID-19 Response has Foreign and Domestic Components Cruse began his presentations by noting the increasing emphasis that the FDA is putting on strengthening internal and external collaboration in meeting its public health mission...

You must be a paid subscriber to continue reading this article. If you are a paid subscriber, please Log in. If you are not a paid subscriber, please subscribe now.

©2020 IPQ Publications